Goodwill and Other Intangible Assets (Tables)

6 Months Ended

Dec. 28, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill [Table Text Block]

Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):

	Consumer Healthcare			Nutritionals		Rx Pharma-ceuticals		API		Specialty Sciences		Total
Balance as of June 29, 2013	$	279.9		$	331.7	$	385.5	$	92.2	$	—	$	1,089.3
Business acquisition	423.7			91.5		316.1		—		1,245.3		2,076.6
Purchase accounting adjustments	(1.9		)	—		1.3		—		—		(0.6		)
Currency translation adjustment	4.1			—		14.3		3.6		—		22.0
Balance as of December 28, 2013	$	705.8		$	423.2	$	717.2	$	95.8	$	1,245.3	$	3,187.3

Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block]

Other intangible assets and related accumulated amortization consisted of the following (in millions):

	December 28, 2013				June 29, 2013
	Gross		Accumulated Amortization		Gross		Accumulated Amortization
Amortizable intangibles:
Distribution, license and supply agreements	$	6,307.3	$	41.7	$	192.7	$	28.9
Developed product technology/formulation and product rights	923.5		255.1		896.8		204.6
Customer relationships	360.2		84.8		358.2		72.4
Non-compete agreements	13.3		7.6		13.3		6.0
Trademarks	12.9		4.7		12.7		4.2
Total	7,617.2		393.9		1,473.7		316.1
Non-amortizable intangibles:
Trade names and trademarks	58.6		—		57.0		—
IPR&D	9.7		—		27.8		—
Total other intangible assets	$	7,685.5	$	393.9	$	1,558.5	$	316.1

Schedule of Intangible Assets, Future Amortization Expense [Table Text Block]

Fiscal Year	Amount
2014(1)	$	214.6
2015	437.8
2016	448.0
2017	444.2
2018	437.2

⁽¹⁾Reflects remaining six months of fiscal 2014.